DiaMedica Therapeutics Inc.
DMAC- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401040
No open-market purchases or sales by DiaMedica Therapeutics Inc. insiders were filed in the last 90 days; 88 institutions reported holding it in 13F filings for Q2 2026, worth $87.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding DiaMedica Therapeutics Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 25 | 32 | +7 |
| Shares | 2.57M | 3.49M | +923.3K (+36.0%) |
| Value | $3.93M | $15.1M | +$11.2M (+283.8%) |
New holders (9)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Paragon Associates & Paragon Associates II Joint Venture | 325,000 | $1.40M | 2.87% |
| Bleichroeder LP | 294,117 | $1.27M | 0.26% |
| EAM Investors, LLC | 270,419 | $1.17M | 0.22% |
| First Manhattan Co | 124,744 | $538.9K | 0.00% |
| Susquehanna International Group, LLP | 16,923 | $73.1K | 0.00% |
| Charles Schwab Investment Management Inc | 13,251 | $57.2K | 0.00% |
| Signaturefd, LLC | 25 | $108 | 0.00% |
| JPMorgan Chase & Co | 21 | $91 | 0.00% |
| Advisor Group Holdings, Inc. | 1 | $4 | 0.00% |
Sold out (2)
Institutions that held DiaMedica Therapeutics Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Renaissance Technologies LLC | 64,508 | $99.0K |
| UBS Group AG | 2,038 | $3.12K |